symbol,statement_type,period_end,line_item,value
SUNPHARMA.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,-1298253839.950611
SUNPHARMA.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.191525
SUNPHARMA.NS,income,2025-03-31 00:00:00,Normalized EBITDA,172367300000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Total Unusual Items,-6778500000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-6778500000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,109290400000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,25753900000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,107473600000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,EBITDA,165588800000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,EBIT,139834900000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Net Interest Income,-2313600000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Interest Expense,2313600000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Interest Income,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Normalized Income,114770646160.0494
SUNPHARMA.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,109290400000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Total Expenses,395304800000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Diluted Average Shares,2396719298.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Basic Average Shares,2396719298.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Diluted EPS,45.6
SUNPHARMA.NS,income,2025-03-31 00:00:00,Basic EPS,45.6
SUNPHARMA.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,109290400000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,109290400000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Net Income,109290400000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Minority Interests,-357100000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,109647500000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,109647500000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Tax Provision,26338800000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Pretax Income,137521300000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,19650400000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Special Income Charges,-6778500000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Other Special Charges,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Write Off,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Impairment Of Capital Assets,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Restructuring And Mergern Acquisition,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-2313600000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,2313600000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Operating Income,125107700000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Operating Expense,287831200000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Other Operating Expenses,167718000000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,25753900000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,25753900000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Selling General And Administration,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
SUNPHARMA.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
SUNPHARMA.NS,income,2025-03-31 00:00:00,Gross Profit,412938900000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Cost Of Revenue,107473600000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Total Revenue,520412500000.0
SUNPHARMA.NS,income,2025-03-31 00:00:00,Operating Revenue,520412500000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-641735193.981903
SUNPHARMA.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.129822
SUNPHARMA.NS,income,2024-03-31 00:00:00,Normalized EBITDA,143773200000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Total Unusual Items,-4943200000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-4943200000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,95763800000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,25566400000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,106626100000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,EBITDA,138830000000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,EBIT,113263600000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Net Interest Income,-2384700000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Interest Expense,2384700000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Interest Income,10229100000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Normalized Income,100065264806.0181
SUNPHARMA.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,95763800000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Total Expenses,373280900000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,734300000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Diluted Average Shares,2400095238.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Basic Average Shares,2400095238.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Diluted EPS,39.9
SUNPHARMA.NS,income,2024-03-31 00:00:00,Basic EPS,39.9
SUNPHARMA.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,95763800000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,95763800000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Net Income,95763800000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Minority Interests,-336500000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,96100300000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,96100300000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Tax Provision,14394500000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Pretax Income,110878900000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,13541900000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Special Income Charges,-4943200000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Other Special Charges,2726300000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Write Off,
SUNPHARMA.NS,income,2024-03-31 00:00:00,Impairment Of Capital Assets,1562600000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Restructuring And Mergern Acquisition,739500000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-2384700000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,2384700000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,10229100000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Operating Income,104303600000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Operating Expense,266654800000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Other Operating Expenses,154181800000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,25566400000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,25566400000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Selling General And Administration,92174000000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,57802600000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,General And Administrative Expense,34371400000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,734300000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Gross Profit,370958400000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Cost Of Revenue,106626100000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Total Revenue,477584500000.0
SUNPHARMA.NS,income,2024-03-31 00:00:00,Operating Revenue,477584500000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-163465323.651236
SUNPHARMA.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.090088
SUNPHARMA.NS,income,2023-03-31 00:00:00,Normalized EBITDA,122923100000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Total Unusual Items,-1814500000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-1814500000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,84735800000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,25304300000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,119424200000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,EBITDA,121108600000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,EBIT,95804300000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Net Interest Income,2125400000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Interest Expense,1720000000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Interest Income,3845400000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Normalized Income,86386834676.34877
SUNPHARMA.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,84735800000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Total Expenses,340015100000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,588700000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Diluted Average Shares,2399334970.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Basic Average Shares,2399334970.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Diluted EPS,35.3
SUNPHARMA.NS,income,2023-03-31 00:00:00,Basic EPS,35.3
SUNPHARMA.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,84735800000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,84735800000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Net Income,84735800000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Minority Interests,-393600000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,85129400000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,85129400000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Tax Provision,8475900000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Pretax Income,94084300000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,796300000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Special Income Charges,-1808300000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Other Special Charges,-208700000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Write Off,1644300000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Impairment Of Capital Assets,302500000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Restructuring And Mergern Acquisition,70200000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,2125400000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,1720000000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,3845400000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Operating Income,92773600000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Operating Expense,220590900000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Other Operating Expenses,37368700000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,25294300000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,25294300000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Selling General And Administration,80447000000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,52262400000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,General And Administrative Expense,28184600000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,588700000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Gross Profit,313364500000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Cost Of Revenue,119424200000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Total Revenue,432788700000.0
SUNPHARMA.NS,income,2023-03-31 00:00:00,Operating Revenue,432788700000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-10960316792.819973
SUNPHARMA.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.239996
SUNPHARMA.NS,income,2022-03-31 00:00:00,Normalized EBITDA,113192800000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Total Unusual Items,-45668700000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-45668700000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,32727300000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,21437400000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,103515400000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,EBITDA,67524100000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,EBIT,46086700000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Net Interest Income,-1273500000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Interest Expense,1273500000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Interest Income,5533700000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Normalized Income,67435683207.18002
SUNPHARMA.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,32727300000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Total Expenses,303264000000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,535400000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Diluted Average Shares,2406419118.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Basic Average Shares,2406419118.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Diluted EPS,13.6
SUNPHARMA.NS,income,2022-03-31 00:00:00,Basic EPS,13.6
SUNPHARMA.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,32727300000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,32727300000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Net Income,32727300000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Minority Interests,-1165500000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,33892800000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,33892800000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Tax Provision,10755000000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Pretax Income,44813200000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,9215100000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Special Income Charges,-45668700000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Other Special Charges,45150600000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Write Off,
SUNPHARMA.NS,income,2022-03-31 00:00:00,Impairment Of Capital Assets,204600000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Restructuring And Mergern Acquisition,
SUNPHARMA.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-1273500000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,1273500000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,5533700000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Operating Income,81000200000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Operating Expense,199748600000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Other Operating Expenses,107583600000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,21437399999.999996
SUNPHARMA.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,21437399999.999996
SUNPHARMA.NS,income,2022-03-31 00:00:00,Selling General And Administration,54685600000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,32817300000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,General And Administrative Expense,21868300000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,535400000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Gross Profit,280748800000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Cost Of Revenue,103515400000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Total Revenue,384264200000.0
SUNPHARMA.NS,income,2022-03-31 00:00:00,Operating Revenue,384264200000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Total Unusual Items,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
SUNPHARMA.NS,income,2021-03-31 00:00:00,EBITDA,
SUNPHARMA.NS,income,2021-03-31 00:00:00,EBIT,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Net Interest Income,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Interest Expense,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Interest Income,2111300000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Normalized Income,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Total Expenses,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,419800000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Basic Average Shares,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Diluted EPS,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Basic EPS,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Net Income,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Minority Interests,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Tax Provision,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Pretax Income,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Special Income Charges,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Other Special Charges,42775700000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Write Off,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Impairment Of Capital Assets,155500000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Restructuring And Mergern Acquisition,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,2111300000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Operating Income,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Operating Expense,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Selling General And Administration,48668500000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,24815900000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,General And Administrative Expense,23852600000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,419800000.0
SUNPHARMA.NS,income,2021-03-31 00:00:00,Gross Profit,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Total Revenue,
SUNPHARMA.NS,income,2021-03-31 00:00:00,Operating Revenue,
